InvestSMART

Brazilian Critical Minerals Limited (ASX: BCM) - Announcements

Current share price for BCM : $0.054 0.001 (1.89%)+

ASX company news and announcements for Brazilian Critical Minerals Limited (BCM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Brazilian Critical Minerals Limited (BCM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Brazilian Critical Minerals Limited (BCM), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Brazilian Critical Minerals Limited (BCM)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$104 Quarterly Activities Report 30 Apr 2024 9:30AM $0.025 $0.053 risen by 112%
$104 Quarterly Appendix 5B Cash Flow Report 30 Apr 2024 8:20AM $0.025 $0.053 risen by 112%
$104 Investor Presentation 29 Apr 2024 8:19AM $0.025 $0.053 risen by 112%
$104 Massive Maiden Mineral Resource for Ema Project 22 Apr 2024 9:00AM $0.025 $0.053 risen by 112%
$104 Trading Halt 18 Apr 2024 9:54AM $0.025 $0.053 risen by 112%
$104 World Class Ionic REE Recoveries Continue 2 Apr 2024 9:51AM $0.021 $0.053 risen by 152.38%
$104 Half Yearly Report and Accounts 15 Mar 2024 3:46PM $0.022 $0.053 risen by 140.91%
$104 World Class REE Recoveries at Ema Project 13 Mar 2024 9:28AM $0.023 $0.053 risen by 130.43%
$104 Appointment Of Managing Director And Non-Executive Chairman 27 Feb 2024 8:00AM $0.024 $0.053 risen by 120.83%
$104 High-Grade Ionic Rare Earth Zone At Ema Expanded By 54% 22 Feb 2024 9:24AM $0.022 $0.053 risen by 140.91%
$104 Extensive Ionic Rare Earth Mineralisation At Ema Project 6 Feb 2024 9:31AM $0.026 $0.053 risen by 103.85%
$104 Final Tres Estados Bioleach Report 30 Jan 2024 9:47AM $0.024 $0.053 risen by 120.83%
$104 CETEM Ammonium Sulphate Leach Ionic Adsorbed Clay Ree Test 29 Jan 2024 11:12AM $0.025 $0.053 risen by 112%
$104 Quarterly Activities/Appendix 5B Cash Flow Report 29 Jan 2024 8:20AM $0.025 $0.053 risen by 116.33%
$104 CEO Retirement 15 Jan 2024 8:17AM $0.023 $0.053 risen by 130.43%
$104 Options - top 20 12 Jan 2024 11:48AM $0.024 $0.053 risen by 120.83%
$104 Option range holdings 12 Jan 2024 11:47AM $0.024 $0.053 risen by 120.83%
$104 Application for quotation of securities - BCM 11 Jan 2024 2:50PM $0.023 $0.053 risen by 130.43%
$104 Change in substantial holding 2 Jan 2024 3:01PM $0.024 $0.053 risen by 120.83%
$104 Prospectus 22 Dec 2023 1:25PM $0.025 $0.053 risen by 112%
$104 Constitution 22 Dec 2023 8:16AM $0.024 $0.053 risen by 120.83%
$104 Change of Director's Interest Notice - Robinson 22 Dec 2023 8:16AM $0.024 $0.053 risen by 120.83%
$104 Independent Expert Report 24 Mar 2009 9:32AM $0.800 $0.053 fallen by 93.38%
$104 Revised Management Internalisation Agreement 23 Mar 2009 10:18AM $0.840 $0.053 fallen by 93.69%
$104 Half Yearly Report and Accounts 27 Feb 2009 11:04AM $1.205 $0.053 fallen by 95.60%

226 - 250 of 300 results

Page 10 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.